期刊文献+

萘酰亚胺类化合物作为抗肿瘤药物的研究进展 被引量:3

下载PDF
导出
摘要 DNA嵌入剂萘酰亚胺是一种新型的抗肿瘤药物,主要分为单萘酰亚胺和双萘酰亚胺。介绍了萘酰亚胺类化合物的发现和发展,并以几个主要代表药物为例,介绍了萘酰亚胺类化合物的抗肿瘤活性、作用机制和临床研究进展,以及国内一些研究组对萘酰亚胺的研究成果。
作者 刘淼
出处 《河南化工》 CAS 2011年第18期6-9,共4页 Henan Chemical Industry
  • 相关文献

参考文献20

  • 1Armitage B. Photoleavage of nucleic acids [ J ]. Chemical Reviews, 1998, 98 (3) : 1171 - 1200.
  • 2Brana M F, Cacho M, Gradillas A, et al. Intercalators as anticancer drugs [ J ]. Current Pharmaceutical Design, 2001, 7 : 1745 - 1780.
  • 3Waring M J, Gonazalez A, Jimenez A, et al. Intercala- tion binding to DNA of antitumor drugs derived from 3 - nitro - 1,8 - naphthalic acid [ J ]. Nucleic Acids Res, 1979, 7:217-230.
  • 4Brana M F, Castellano J M, Roidan C M, et al. Synthe- sis and mode ( s ) of action of a new series of imide deriva- tives of 3 - nitro - 1,8 - naphthalic acid [ J ]. Cancer Chemother Pharmacol, 1980, 4 : 61 - 66.
  • 5Brana M F, Ramos A. Naphthalimides as anticancer a- gents: synthesis and biological activity [J ]. Curr Med Chem Anti Cancer Agents, 2001, 1 (3) : 237 - 255.
  • 6朱虹,丁健.萘酰亚胺类化合物作为抗肿瘤药物的研发现状[J].中国新药杂志,2007,16(10):742-747. 被引量:8
  • 7Brana M F, Sanz A M, Castellano J M, et al. Syntehsis and Cytostatic Activity of Benz (de) iso - quinoline - 1, 3 - diones. Structure - activity Relationships [ J ]. Eur J Med Chem Chim Ther,1981, 16 : 207 -212.
  • 8Hsiang Y H, Jiang J B, Liu L F. Topoisomerase Ⅱ - mediated DNA cleavage by amonafide and its structural analogs[J ]. Mol Pharmacol, 1989, 36:371 -376.
  • 9Allen S L, Kolitz J E, Lundberg A, et al. Phase I stud- y of amonafide + cytosine arabinoside (AraC) in pa- tients with poor risk acute myeloid leukemia (AML) [ J ]. J Clin Oncol, 2005,23 [ 16 Suppl ]:S6602.
  • 10Innocenti F, Iyer L, Ratain M J. Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan [J ]. V Drug Metab Dispos, 2001, 29 (4 Pt 2 ) : 596 - 600.

二级参考文献62

  • 1Filosa R, Peduto A, Micco SD, et al. Molecular modeling studies, synthesis and biological activity of a series of novel bisnaphthalimides and their development as new DNA topoisomerase II inhibitors [J]. Bioorg Med Chem, 2009, 17:13-24.
  • 2Qian XH, Li ZG, Yang Q. Highly efficient antitumor agents of heterocycles containing sulfur atom: linear and angular thiazonaphthalimides against human lung cancer cell in vitro [J]. Bioorg Med Chem, 2007, 15: 6846-6851.
  • 3Brana MF, Cacho M, Garcia MA, et al. New analogues of amonafide and elinafide, containing aromatic heterocycles: synthesis, antitumor activity, molecular modeling, and DNA binding properties [J]. J Med Chem, 2004, 47: 1391-1399.
  • 4Wang CJ, Delcros JG. Biggerstaff J, et al. Synthesis and biological evaluation of N^1-(anthracen-9-ylmethyl)triamines as molecular recognition elements for the polyamine transporter [J]. J Med Chem, 2003, 46: 2663-2671.
  • 5Wang JH, Xie SQ, Li Y J, et al. Synthesis and evaluation of unsymmetrical polyamine derivatives as antitumor agents [J]. Bioorg Med Chem, 2008, 16: 7005-7012.
  • 6Xie SQ, Cheng PF, Liu GC, et al. Synthesis and bioevaluation of N-(arylalkyl)-homospermidine conjugates [J]. Bioorg Med Chem Lett, 2007, 17: 4471-4475.
  • 7Tian ZY, Xie SQ, Du YW, et al. Synthesis, cytotoxicity and apoptosis of naphthalimide polyamine conjugates as antitumor agents [J]. Eur J Med Chem, 2009, 44: 393-399.
  • 8Li F, Cui JN, Guo LY, et al. Molecular design, chemical synthesis, and biological evaluation of '4-1' pentacyclic aryl/ heteroaryl-imidazonaphthalimides [J]. Bioorg Med Chem, 2007, 15: 5114-5121.
  • 9Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays [J]. J Immunol Methods, 1983, 65: 55-63.
  • 10Kamal A, Reddy BSN, Reddy GSK, et al. Design and synthesis of C-8 linked pyrrolobenzodiazepine-naphthalimide hybrids as anti-tumour agents [J]. Bioorg Med Chem Lett, 2002, 12: 1933-1935.

共引文献29

同被引文献15

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部